Sponsors

Tepnel extends licence agreement with Luminex

Tepnel Life Sciences has agreed an extension of the licence with Luminex for access to the Luminex xMAP platform. The Luminex xMAP technology is incorporated in TepnelÆs innovative molecular diagnostics products.

Tepnel’s LifeMatch products are used for the measurement and detection of human leucocyte antigen (HLA) markers, which are used in the field of bone marrow and solid organ transplantation. These products permit the rapid analysis of a donor’s HLA type to determine if they are a potential match to a patient awaiting transplantation.

Tepnel develops highly multiplexed DNAand protein-based assays and user-friendly software for its successful LifeMatch product line. The Luminex technology allows Tepnel Lifecodes users to analyse up to 100 simultaneous reactions on a single patient sample.

www.tepnel.com

Latest Issues

BSMT 40th Anniversary Microbiology Conference

RAF Museum, Hendon, London NW9 5LL
15 May, 2025

Transforming Digital Pathology & AI: The Path Forward

Royal College Of Physicians Of Edinburgh
15 May, 2025

The 10 Year Plan - Clinical Innovations Expo

Jubilee Hotel and Conference Centre, Nottingham, UK
15 May, 2025